ArticlePharmaceuticals (Basel, Switzerland)2026

Identification of Novel Extracellular-Signal-Regulated Kinase 2 Inhibitors Through Machine Learning-Driven De Novo Design, Molecular Docking, and Free-Energy Perturbation.

Ibrahim A Alsarra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.